CRISPR Mediated Transactivation in the Human Disease Vector Aedes Aegypti
Michelle A. Bui,Elena Dalla Benetta,Yuemei Dong,Yunchong A. Zhao,Ting W. Yang,Ming Li,Igor A. S. Antoshechkin,Anna Buchman,Vanessa A. Bottino-Rojas,Anthony A. James,Michael W. A. Perry,George Dimopoulos,Omar S. A. Akbari
DOI: https://doi.org/10.1371/journal.ppat.1010842
IF: 7.464
2023-01-01
PLoS Pathogens
Abstract:Author summaryThe mosquito, Aedes aegypti is a major vector of arthropod-borne viruses such as Yellow Fever, Chikigunya, and Zika virus. To prevent the spread of disease, the ability to control and reduce Ae. aegypti populations are critical. Historically, this has been accomplished using chemical insecticides. However, insecticides are expensive, non-specific, and have led to the development of resistance within some mosquito populations. Therefore, alternative methods have been sought after. In particular, the development of genetic-based control strategies have been of focus. Current genetic-based tools for Ae. aegypti depend upon disrupting genes that can lead to a reduction of mosquito population size or the prevention of disease transmission. Other tools focus on inserting foreign DNA that can encode mechanisms for disease resistance or encourage continued inheritance of foreign DNA within populations. Despite all these methods there has yet to be a method of inducing expression of the mosquitoes own genes within their own genome. Here we generated a CRISPRactivation (CRISPRa) system in Ae. aegypti and demonstrated its efficacy through activating the expression of the developmental genes even-skipped (eve) and hedgehog (hh) as well as regulator of an immune pathway AaRelI. As a major insect vector of multiple arboviruses, Aedes aegypti poses a significant global health and economic burden. A number of genetic engineering tools have been exploited to understand its biology with the goal of reducing its impact. For example, current tools have focused on knocking-down RNA transcripts, inducing loss-of-function mutations, or expressing exogenous DNA. However, methods for transactivating endogenous genes have not been developed. To fill this void, here we developed a CRISPR activation (CRISPRa) system in Ae. aegypti to transactivate target gene expression. Gene expression is activated through pairing a catalytically-inactive ('dead') Cas9 (dCas9) with a highly-active tripartite activator, VP64-p65-Rta (VPR) and synthetic guide RNA (sgRNA) complementary to a user defined target-gene promoter region. As a proof of concept, we demonstrate that engineered Ae. aegypti mosquitoes harboring a binary CRISPRa system can be used to effectively overexpress two developmental genes, even-skipped (eve) and hedgehog (hh), resulting in observable morphological phenotypes. We also used this system to overexpress the positive transcriptional regulator of the Toll immune pathway known as AaRel1, which resulted in a significant suppression of dengue virus serotype 2 (DENV2) titers in the mosquito. This system provides a versatile tool for research pathways not previously possible in Ae. aegypti, such as programmed overexpression of endogenous genes, and may aid in gene characterization studies and the development of innovative vector control tools.